A Study of Single-dose MY008211A in Healthy Adults

NCT05642585 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG: MY008211A tablets
DRUG: Placebo

Sponsor

Wuhan Createrna Science and Technology Co., Ltd